Comparative cardioprotective effects and mechanisms of vitamin E and lisinopril against ischemic reperfusion induced cardiac toxicity

Environmental Toxicology and Pharmacology

Volumn 35, Issue 2, 2013, Pages 207-217

  Mohanty, I Ray ^a   Arya, D S ^a   Dinda, A ^b   Gupta, S K ^c  

^a Department of Pharmacology ^*  (India)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^c DELHI INSTITUTE OF PHARMACEUTICAL SCIENCES AND RESEARCH   (India)

Author keywords

Ischemia Reperfusion injury; Lisinopril; Oxidative stress; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; CATALASE; CREATINE KINASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; LISINOPRIL; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CARDIOTOXICITY; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFICACY; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEMODYNAMIC PARAMETERS; HISTOPATHOLOGY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; TREATMENT DURATION; VALIDATION PROCESS;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTIOXIDANTS; ARTERIAL PRESSURE; BLOOD PRESSURE; DISEASE MODELS, ANIMAL; HEART RATE; LISINOPRIL; MALE; MYOCARDIAL REPERFUSION INJURY; PROTECTIVE AGENTS; RATS; RATS, WISTAR; VENTRICULAR FUNCTION, LEFT; VITAMIN E;

EID: 84872378854     PISSN: 13826689     EISSN: 18727077     Source Type: Journal    
DOI: 10.1016/j.etap.2012.12.003     Document Type: Article

References (27)

1. Aebi H. Catalase. Methods of Enzymatic Analysis 1974, vol. 2:213-215. edition II.
2. Becker L.C., Ambrosio G. Myocardial consequences of reperfusion. Prog. Cardiovasc. Dis. 1987, 30:23-44.
3. Braunwald E., Kloner R.A. Myocardial reperfusion: a double-edged sword?. J. Clin. Invest. 1985, 76(5):1713-1719.
4. 2 as a mediator of UVB-induced apoptosis in keratinocytes. Free Radic. Res. 2003, 37(6):655-663.
5. Coombes J.S., Powers S.K., Demirel H.A., Hamilton K.L., Jessup J., Vincent H.K., Shanely R.A. Vitamin E deficiency fails to affect myocardial performance during in vivo ischemia-reperfusion. Int. J. Vitam. Nutr. Res. 2000, 70(6):293-300.
6. Doĝan R., Doĝan R., Farsak B., Isbir S., Sarigül A., Tuncer M., Kilinç K. Protective effect of lisinopril against ischemia-reperfusion injury in isolated guinea pig hearts. J. Cardiovasc. Surg. (Torino) 2001, 42(1):43-48.
7. Ferrari R., Guardigli G., Mele D., Percoco G.F., Ceconi C., Curello S. Oxidative stress during myocardial ischaemia and heart failure. Curr. Pharm. Des. 2004, 10(14):1699-1711.
8. Fiordaliso F., Cuccovillo I., Bianchi R., Bai A., Doni M., Salio M., De Angelis N., Ghezzi P., Latini R., Masson S. Cardiovascular oxidative stress is reduced by an ACE inhibitor in a rat model of streptozotocin-induced diabetes. Life Sci. 2006, 79(June (2)):121-129.
9. Frascarelli S., Ghelardoni S., Ronca-Testoni S., Zucchi R. Cardioprotective effect of zofenopril in perfused rat heart subjected to ischemia and reperfusion. J. Cardiovasc. Pharmacol. 2004, 43(2):294-299.
10. Galinanes M., Lawson C.S., Ferrari R., Limb G.A., Derias N.W., Hearse D.J. Early and late effects of leukopenic reperfusion on the recovery of cardiac contractile function. Studies in the transplanted and isolated blood-perfused rat heart. Circulation 1993, 88(2):673-683.
11. Hasan A., McDonough K.H. Effects of short term ischemia and reperfusion on coronary vascular reactivity and myocardial function. Life Sci. 1995, 57(23):2171-2185.
12. Hearse D.J., Bolli R. Reperfusion induced injury: manifestations, mechanisms, and clinical relevance. Cardiovasc. Res. 1992, 26(2):101-108.
13. Holt W.W., Wendland M.F., Derugin N., Wolfe C., Saeed M., Higgins C.B. Effects of nicardipine, a calcium antagonist, on myocardial salvage and high energy phosphate stores in reperfused myocardial injury. J. Am. Coll. Cardiol. 1990, 16(7):1736-1744.
14. Lamprecht W., Stan F., Weisser H., Heinz F. Determination of creatine phosphate and adenosine triphosphate with creatine kinase. Methods of Enzymatic Analysis 1974, 1776-1778. Academic Press, New York. H.U. Bergmeyer (Ed.).
15. Lowry O.H., Rosebrough N.J., Farr A.I. Protein measurements with the Folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
16. Maron M.S., Depierre J.W., Manmerik B. Level of glutathione, glutathione reductase and glutathione-s-transferase activity in rat lung and liver. Biochem. Biophys. Acta 1979, 82:67-78.
17. Mazzotta G., Vecchio C. Angiotensin converting enzyme inhibitors during acute phase of myocardial infarct. J. Ital. Cardiol. 1994, 24(1):59-70.
18. McCord J.M. Are free radicals a major culprit?. Therapeutic Approaches to Myocardial Infarct Size Limitation 1984, 209-218. Raven Press, New York. D.J. Hearse (Ed.).
19. Mishra H.P., Fridovich I. The oxidation of phenylhydrazine: superoxide and mechanisms. Biochemistry 1976, 15:681-687.
20. Ohkawa H., Ohishi N., Yagi K. Assay of lipid peroxide in animal tissue by thiobarbituric acid reaction. Anal. Biochem. 1995, 95:351-358.
21. Opie L.H. Reperfusion injury and its pharmacologic modification. Circulation 1989, 80:1049-1092.
22. Paglia D.E., Valentine W.N. Studies on the quantitative and qualitative characterization of erythrocyte peroxidase. J. Lab. Clin. Med. 1967, 2:158.
23. Reimer K.A., Lowe J.E., Rasmussen M.M., Jennings R.B. The wave-front phenomenon of ischemic cell death. Myocardial infarct size vs duration of coronary occlusion in dogs. Circulation 1977, 56(5):786-794.
24. Sun Y., Ratajska A., Weber K.T. Inhibition of angiotensin-converting enzyme and attenuation of myocardial fibrosis by lisinopril in rats receiving angiotensin II. J. Lab. Clin. Med. 1995, 126(1):95-101.
25. Veeravalli K.K., Akula A., Routhu K.V., Kota M.K. Infarct size limiting effect of apstatin alone and in combination with enalapril, lisinopril and ramipril in rats with experimental myocardial infarction. Pharmacol. Res. 2003, 48(6):557-563.
26. Yu A.W., Olabi A.Z., Gupta D.K., Zhou F.Q., Gandhi V.C., Ing T.S. Effects of euhydric peritoneal dialysis solutions containing mixture of bicarbonate and lactate or lactate alone on neutrophilic superoxide production. ASAIO J. 1994, 40(3):M900-M901.
27. Zornoff L.A., Matsubara B.B., Matsubara L.S., Paiva S.A., Spadaro J. Early rather than delayed administration of lisinopril protects the heart after myocardial infarction in rats. Basic Res. Cardiol. 2000, 95(3):208-214.